|
Information For:
|
Revision Bulletin
Etodolac Extended-Release Tablets
In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has approved the Etodolac Extended-Release Tablets Monograph Revision Bulletin. The Revision Bulletin adds a Dissolution test. The Etodolac Extended-Release Tablets Monograph Revision Bulletin supersedes the monograph in USP 32–NF 27 until it is printed in the USP 32–NF 27 Second Supplement, which will be released June 1, 2009. Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or mrm@usp.org). Download
the Etodolac Extended-Release Tablets Monograph Transferred to Accelerated Revision History section: 26 February 2010 What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||